Community eye-worker program in Nepal
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a village-based approach to bring eye care closer to older community members. If you live in the right area and are willing to participate, it may help improve access to eye screening and services.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in the catchment area of Bharatpur Eye Hospital or Lumbini Eye Institute
- Your area can be reached by a regular (non-4WD) vehicle
- You live in an urban or peri-urban (near-city) area
- You are 60 years old or older
- You were living in the community during the census period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at better ways to help people get follow-up eye care after a screening. If you were in the VIEW II study and were referred to an eye hospital, this trial may offer strategies to support you in getting that care.
This study tests whether a special glaucoma awareness program helps people stick to their treatment plan. If you have glaucoma and get care at a hospital in Nepal, joining might improve how well you manage your eye condition.
This trial is studying people living in Char Fasson, Bangladesh, to see who might have undiagnosed eye problems. It's a local screening program to catch eye issues early.
This trial screens adults in Rawalpindi for eye problems and helps them get referred to a specialist hospital to prevent avoidable blindness. If you have an untreated eye issue, this program can connect you with the care you need.
This trial collects health information from people with diabetes or aged 65 and older to help improve eye care. By joining, you allow your medical data to be used for research without any extra tests or treatments.
This study uses a special eye scan to take detailed pictures of the back of the eye in people with various retinal conditions. It may help doctors better understand and manage these diseases.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.